| 1 | 1548940 | Selected pharmacologic characteristics of idarubicin and idarubicinol. | Leukemia | 1992 |
1 |
| 2 | 8690513 | Cellular pharmacology of idarubicinol in multidrug-resistant LoVo cell lines. | Int J Cancer | 1996 Jul 3 |
1 |
| 3 | 14565163 | Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. | Neuro Oncol | 2003 Oct |
4 |
| 4 | 19783832 | Cholesterol worships a new idol. | J Mol Cell Biol | 2009 Dec |
3 |
| 5 | 20410187 | Regulation of divalent metal transporter 1 (DMT1) non-IRE isoform by the microRNA Let-7d in erythroid cells. | Haematologica | 2010 Aug |
1 |
| 6 | 21069265 | Suppression of Idol expression is an additional mechanism underlying statin-induced up-regulation of hepatic LDL receptor expression. | Int J Mol Med | 2011 Jan |
2 |
| 7 | 21685362 | The IDOL-UBE2D complex mediates sterol-dependent degradation of the LDL receptor. | Genes Dev | 2011 Jun 15 |
1 |
| 8 | 21734303 | Distinct functional domains contribute to degradation of the low density lipoprotein receptor (LDLR) by the E3 ubiquitin ligase inducible Degrader of the LDLR (IDOL). | J Biol Chem | 2011 Aug 26 |
1 |
| 9 | 21765216 | The N342S MYLIP polymorphism is associated with high total cholesterol and increased LDL receptor degradation in humans. | J Clin Invest | 2011 Aug |
1 |
| 10 | 21859674 | Transcriptional and posttranscriptional control of cholesterol homeostasis by liver X receptors. | Cold Spring Harb Symp Quant Biol | 2011 |
1 |
| 11 | 22059152 | An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. | Cancer Discov | 2011 Oct |
1 |
| 12 | 22109552 | FERM-dependent E3 ligase recognition is a conserved mechanism for targeted degradation of lipoprotein receptors. | Proc Natl Acad Sci U S A | 2011 Dec 13 |
3 |
| 13 | 22331829 | Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) trial. | Circ Cardiovasc Genet | 2012 Apr 1 |
1 |
| 14 | 22347519 | Epigenetic silencing of miR-34a in human prostate cancer cells and tumor tissue specimens can be reversed by BR-DIM treatment. | Am J Transl Res | 2012 |
2 |
| 15 | 22610076 | miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. | Carcinogenesis | 2012 Jul |
2 |
| 16 | 22752225 | Induction of the transcriptional repressor ZBTB4 in prostate cancer cells by drug-induced targeting of microRNA-17-92/106b-25 clusters. | Mol Cancer Ther | 2012 Sep |
1 |
| 17 | 22936343 | Feedback regulation of cholesterol uptake by the LXR-IDOL-LDLR axis. | Arterioscler Thromb Vasc Biol | 2012 Nov |
5 |
| 18 | 23107276 | Association of MYLIP rs3757354 SNP and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han populations. | Lipids Health Dis | 2012 Oct 29 |
1 |
| 19 | 23435093 | From evolution to revolution: miRNAs as pharmacological targets for modulating cholesterol efflux and reverse cholesterol transport. | Pharmacol Res | 2013 Sep |
4 |
| 20 | 23598417 | MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway. | Int J Mol Sci | 2013 Apr 18 |
1 |
| 21 | 23678170 | Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE. | J Virol | 2013 Jul |
1 |
| 22 | 24045110 | Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing. | J Gen Virol | 2013 Dec |
4 |
| 23 | 24252850 | The natural inhibitor of DNA topoisomerase I, camptothecin, modulates HIF-1α activity by changing miR expression patterns in human cancer cells. | Mol Cancer Ther | 2014 Jan |
1 |
| 24 | 24299514 | miR-199a-5p silencing regulates the unfolded protein response in chronic obstructive pulmonary disease and α1-antitrypsin deficiency. | Am J Respir Crit Care Med | 2014 Feb 1 |
1 |
| 25 | 24334028 | β-arrestin1-biased β1-adrenergic receptor signaling regulates microRNA processing. | Circ Res | 2014 Feb 28 |
2 |
| 26 | 24447928 | Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells. | Int J Mol Sci | 2014 Jan 20 |
2 |
| 27 | 24872388 | Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S. | Cancer Res | 2014 Aug 15 |
1 |
| 28 | 25007957 | MiR-9 regulates the post-transcriptional level of VEGF165a by targeting SRPK-1 in ARPE-19 cells. | Graefes Arch Clin Exp Ophthalmol | 2014 Sep |
1 |
| 29 | 25023731 | AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia. | Circ Res | 2014 Aug 29 |
1 |
| 30 | 25329888 | Effects of miR-33a-5P on ABCA1/G1-mediated cholesterol efflux under inflammatory stress in THP-1 macrophages. | PLoS One | 2014 |
5 |
| 31 | 25394495 | Docosahexanoic acid modifies low-density lipoprotein receptor abundance in HepG2 cells via suppression of the LXRα-Idol pathway. | Mol Med Rep | 2015 Mar |
3 |
| 32 | 25427715 | Deep Sequencing the microRNA profile in rhabdomyosarcoma reveals down-regulation of miR-378 family members. | BMC Cancer | 2014 Nov 25 |
2 |
| 33 | 25625875 | Combination treatment with doxorubicin and microRNA-21 inhibitor synergistically augments anticancer activity through upregulation of tumor suppressing genes. | Int J Oncol | 2015 Apr |
3 |
| 34 | 25927920 | IDOL N342S Variant, Atherosclerosis Progression and Cardiovascular Disorders in the Italian General Population. | PLoS One | 2015 |
1 |
| 35 | 25928907 | MicroRNA expression profiles in liver and colon of sexually immature gilts after exposure to Fusarium mycotoxins. | Pol J Vet Sci | 2015 |
2 |
| 36 | 25990668 | Association study of the miRNA-binding site polymorphisms of CDKN2A/B genes with gestational diabetes mellitus susceptibility. | Acta Diabetol | 2015 Oct |
2 |
| 37 | 26153245 | Alterations of a Cellular Cholesterol Metabolism Network Are a Molecular Feature of Obesity-Related Type 2 Diabetes and Cardiovascular Disease. | Diabetes | 2015 Oct |
1 |
| 38 | 26527619 | A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes. | Mol Cell Biol | 2016 Jan 15 |
1 |
| 39 | 26666640 | The Deubiquitylase USP2 Regulates the LDLR Pathway by Counteracting the E3-Ubiquitin Ligase IDOL. | Circ Res | 2016 Feb 5 |
1 |
| 40 | 26719329 | Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake. | J Biol Chem | 2016 Feb 26 |
2 |
| 41 | 26786161 | Stable liver-specific expression of human IDOL in humanized mice raises plasma cholesterol. | Cardiovasc Res | 2016 May 1 |
1 |
| 42 | 26846634 | Foiling IDOL to Help Control Cholesterol. | Circ Res | 2016 Feb 5 |
1 |
| 43 | 27071970 | RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol. | Circ Cardiovasc Genet | 2016 Jun |
6 |
| 44 | 27284341 | MicroRNA-138 suppresses proliferation, invasion and glycolysis in malignant melanoma cells by targeting HIF-1α. | Exp Ther Med | 2016 Jun |
1 |
| 45 | 27353169 | MiR-548an, Transcriptionally Downregulated by HIF1α/HDAC1, Suppresses Tumorigenesis of Pancreatic Cancer by Targeting Vimentin Expression. | Mol Cancer Ther | 2016 Sep |
1 |
| 46 | 27465833 | Evaluation of in vivo antitumor effects of low-frequency ultrasound-mediated miRNA-133a microbubble delivery in breast cancer. | Cancer Med | 2016 Sep |
5 |
| 47 | 27649261 | MiR-pharmacogenetics of methotrexate in childhood B-cell acute lymphoblastic leukemia. | Pharmacogenet Genomics | 2016 Nov |
1 |
| 48 | 27667021 | Proliferation of metanephric mesenchymal cells is inhibited by miR-743a-mediated WT1 suppression in vitro. | Mol Med Rep | 2016 Nov |
2 |
| 49 | 27769200 | Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells. | BMC Cancer | 2016 Oct 21 |
1 |
| 50 | 27997916 | Circulating miR-181a as a Potential Novel Biomarker for Diagnosis of Acute Myocardial Infarction. | Cell Physiol Biochem | 2016 |
1 |